drugset / Trial / NCT04111497
Glasdegib for Chronic Graft-Versus-Host Disease
NaSingle-groupOpen-labelTreatment
Summary
This phase I/II trial studies whether glasdegib is helpful in treating sclerosis associated with chronic graft-versus-host disease. It will also investigate the safety of glasdegib in treating patients with chronic graft-versus-host disease.
Timeline
- Start
- 2019-12-03
- Primary completion
- 2023-08-23
- Completion
- 2023-08-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glasdegib | Small molecule | — | Oral |